MAPT and Alzheimer disease: These findings underscore the role of impaired clearance of neurotoxic products in AD pathophysiology, as aging‐related dysfunction of the glymphatic system or meningeal lymphatics promotes Aβ and Tau accumulation in both animal models and humans.228, 229